Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer [Phase 2]
Phase 2 trial comparing eribulin mesylate versus ixabepilone in causing or worsening neuropathy in advanced breast cancer; results completed…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study) [Phase 3]
A Phase 3 comparative study evaluating scalp cooling system versus chemical cold cap for primary breast cancer is ongoing, with status curre…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy [Phase 3]
Phase 3 trial update on alternative non-cross-resistant adjuvant chemotherapy for operable breast cancer showing primary chemotherapy non-re…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer [Phase 3]
Phase 3 trial comparing neoadjuvant endocrine therapy versus chemotherapy in premenopausal patients with ER-positive, HER2-negative breast c…
-
CLINICAL_TRIALS trial_result · 2021-11-29Clinical Trial Update: Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy [Phase 2]
Phase 2 clinical study evaluating adjuvant therapy in post-menopausal women with breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer [Phase 2]
Phase 2 clinical trial update for RC48 as neoadjuvant chemotherapy in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: CISPLATIN + AZD-1775 In Breast Cancer [Phase 2]
Phase 2 trial assessing cisplatin plus AZD-1775 in triple-negative metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients [Phase 2]
Phase 2 trial update of pegylated liposomal doxorubicin with cyclophosphamide in HER2-negative stage I–II breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC [Phase 4]
Phase 4 trial investigating cipterbin combined with vinorelbine for metastatic breast cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Automated Method for Breast Cancer Detection [NA]
A terminated clinical trial evaluated an automated method for detecting breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] [Phase 3]
Phase 3 PALOMA-4 evaluated palbociclib plus letrozole versus placebo plus letrozole as first-line therapy in Asian postmenopausal women with…
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases [Phase 1, Phase 2]
Phase 1/2 trial evaluating a Toll-like receptor 7 agonist with cyclophosphamide and radiotherapy for breast cancer with skin metastases has …
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer [Phase 2]
Phase 2 clinical trial update for intratumoral INT230-6 in breast cancer (INVINCIBLE trial) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Evaluation of BIS for Quantification of Lymphedema
Clinical trial update reports results for evaluating bioimpedance spectroscopy (BIS) to quantify lymphedema in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic [Phase 3]
Phase 3 trial evaluating exemestane with or without entinostat in recurrent hormone receptor-positive, HER2-negative breast cancer that is l…
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer [Phase 2]
Phase II biomarker trial of gelatin-encapsulated American ginseng root extract (LEAG) in breast cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer [Phase 2]
Phase 2 trial of talazoparib as neoadjuvant therapy in germline BRCA1/2 mutation-bearing, HER2-negative early breast cancer; the study is te…
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer [Phase 1]
Phase 1 trial evaluating autologous GM-CSF-secreting cancer cell vaccine for operable breast cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: ESP in Breast Surgery Due to Cancer [Phase 4]
Phase 4 clinical trial update on ESP in breast surgery for breast cancer, focusing on pain management in an acute setting.
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Trastuzumab Emtansine in Patients With Previously Treated HER2-Positive Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating venetoclax in combination with trastuzumab emtansine in previously treated HER2-positive locally advanced or me…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Effect of GM1 in Prevention of Taxanes Induced Neurotoxicity in Operable Breast Cancer [Phase 3]
Phase 3 trial evaluating whether GM1 prevents taxane-induced neurotoxicity in operable breast cancer; study completed.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors [Phase 2]
Phase 2 clinical trial update on a scalable lifestyle program for nutrition and physical activity in stage 0-III breast cancer survivors; st…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 1, Phase 2]
A clinical trial update reports the completion of a Phase 1/2 study evaluating Talimogene laherparepvec with neoadjuvant chemotherapy for tr…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating camrelizumab in combination with pegylated liposomal doxorubicin and losartan for patients with triple-neg…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating veliparib with temozolomide or with carboplatin/paclitaxel versus placebo in BRCA1/2-mutated metastatic breast canc…